Figure 7From: Relationship between the area of isopters and Vigabatrin dosage during two years of observation Results of five consecutive examinations of semi-automated kinetic perimetry (Octopus 101) of a patient with Vigabatrin-attributable visual field loss. Mean daily dose 1950 mg, cumulative dose 1230 g, duration of VGB treatment - 24 months. Other antiepileptic drug: oxcarbazepin.Back to article page